• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本 2017 年血管异常临床实践指南

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

机构信息

Department of Radiology, St. Marianna University School of Medicine, Kawasaki, Japan.

Department of Plastic Surgery, Wound Repair and Regeneration, Fukuoka University, School of Medicine, Fukuoka, Japan.

出版信息

J Dermatol. 2020 May;47(5):e138-e183. doi: 10.1111/1346-8138.15189. Epub 2020 Mar 22.

DOI:10.1111/1346-8138.15189
PMID:32200557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7317503/
Abstract

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQ) were decided based on the important clinical issues. For document retrieval, key words for published work searches were set for each CQ, and work published from 1980 to the end of September 2014 was searched in PubMed, Cochrane Library and Japana Centra Revuo Medicina databases. The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System technique. A total of 33 CQ were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

摘要

目的在于制定指南以实施当前最佳治疗,通过组织有效的和高效的治疗血管瘤和血管畸形,确认安全性并使治疗系统化,采用循证医学技术,旨在改善治疗效果。临床问题(CQ)是基于重要的临床问题来确定的。为了进行文献检索,为每个 CQ 设置了已发表文献检索的关键词,并在 PubMed、Cochrane Library 和 Japana Centra Revuo Medicina 数据库中检索了 1980 年至 2014 年 9 月底发表的文献。通过循证医学网络分布系统技术确定了系统评价获得的证据强度和推荐意见。共使用 33 个 CQ 来编写建议,涉及的主题包括切除术、硬化疗法/栓塞术、药物治疗、激光治疗、放射治疗和其他保守治疗的疗效、病变部位和症状之间的适当治疗差异、适当的治疗时机和检查以及决定诊断的病理诊断。因此,制定了 2017 年日本血管异常临床实践指南,作为血管异常管理的循证指南。

相似文献

1
Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.日本 2017 年血管异常临床实践指南
J Dermatol. 2020 May;47(5):e138-e183. doi: 10.1111/1346-8138.15189. Epub 2020 Mar 22.
2
Japanese clinical practice guidelines for vascular anomalies 2017.《2017年日本血管异常临床实践指南》
Pediatr Int. 2020 Mar;62(3):257-304. doi: 10.1111/ped.14077. Epub 2020 Mar 22.
3
Japanese clinical practice guidelines for vascular anomalies 2017.2017 年日本血管异常临床实践指南。
Jpn J Radiol. 2020 Apr;38(4):287-342. doi: 10.1007/s11604-019-00885-5.
4
[Vascular anomalies: information documents].[血管异常:信息文件]
Ann Chir Plast Esthet. 2011 Jun;56(3):254-64. doi: 10.1016/j.anplas.2009.11.014. Epub 2010 Jul 3.
5
Treatment of unusual vascular lesions: usefulness of sclerotherapy in lymphangioma circumscriptum and acquired digital arteriovenous malformation.特殊血管病变的治疗:硬化疗法在局限性淋巴管瘤和后天性指(趾)动静脉畸形中的应用价值
Dermatol Surg. 2005 Nov;31(11 Pt 1):1451-3. doi: 10.2310/6350.2005.31216.
6
Pediatric vascular malformations: pathophysiology, diagnosis, and the role of interventional radiology.小儿血管畸形:病理生理学、诊断和介入放射学的作用。
Cardiovasc Intervent Radiol. 2011 Aug;34(4):691-704. doi: 10.1007/s00270-011-0123-0. Epub 2011 Mar 16.
7
Vascular anomalies of the mediastinum.纵隔血管异常
Semin Pediatr Surg. 1999 May;8(2):92-8. doi: 10.1016/s1055-8586(99)70023-5.
8
Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group.儿童期血管瘤和血管畸形的影像学及治疗方法
Pediatr Radiol. 1999 Dec;29(12):879-93. doi: 10.1007/s002470050718.
9
[Interdisciplinary management of extracranial vascular anomalies].[颅外血管异常的多学科管理]
HNO. 2022 May;70(5):380-388. doi: 10.1007/s00106-022-01163-z. Epub 2022 Apr 14.
10
Optimal treatment of vascular birthmarks.血管性胎记的最佳治疗方法。
Am J Clin Dermatol. 2003;4(11):745-56. doi: 10.2165/00128071-200304110-00003.

引用本文的文献

1
Analysis of infantile hemangioma without proliferation after birth.出生后无增殖的婴儿血管瘤分析。
GHM Open. 2024 Nov 30;4(2):80-83. doi: 10.35772/ghmo.2023.01022.
2
Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma.25例婴儿血管瘤口服普萘洛尔给药策略的回顾性评估
J Plast Reconstr Surg. 2023 Oct 12;3(2):94-98. doi: 10.53045/jprs.2023-0016. eCollection 2024 Apr 27.
3
Post-Hoc Analysis of a Multicenter Clinical Trial: Correlation of Coagulation Factor Changes and MRI-Defined Treatment Outcomes After Sclerotherapy for Venous Malformations.

本文引用的文献

1
Mechanisms of propranolol action in infantile hemangioma.普萘洛尔治疗婴儿血管瘤的作用机制。
Dermatoendocrinol. 2015 Jan 26;6(1):e979699. doi: 10.4161/19381980.2014.979699. eCollection 2014 Jan-Dec.
2
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies.血管异常分类:国际血管异常研究学会的建议
Pediatrics. 2015 Jul;136(1):e203-14. doi: 10.1542/peds.2014-3673. Epub 2015 Jun 8.
3
Propranolol induced hypoglycemia.普萘洛尔诱发低血糖症。
一项多中心临床试验的事后分析:静脉畸形硬化治疗后凝血因子变化与MRI定义的治疗结果的相关性
J Clin Med. 2025 Jan 30;14(3):905. doi: 10.3390/jcm14030905.
4
Effect and safety of ethanolamine oleate in sclerotherapy in patients with difficult-to-resect venous malformations: A multicenter, single-arm study.油酸乙醇胺在难以切除的静脉畸形硬化治疗中的疗效与安全性:一项多中心单臂研究。
PLoS One. 2025 Jan 31;20(1):e0303130. doi: 10.1371/journal.pone.0303130. eCollection 2025.
5
Algorithm-based Management of Infantile Hemangiomas: Reducing Sequelae and Surgical Interventions.基于算法的婴幼儿血管瘤管理:减少后遗症和手术干预
Plast Reconstr Surg Glob Open. 2024 Sep 19;12(9):e6192. doi: 10.1097/GOX.0000000000006192. eCollection 2024 Sep.
6
A Rare Coexistence of Mesenteric Lymphangioma and Ulcerative Colitis, Obscuring the Right Cause of Symptoms.肠系膜淋巴管瘤与溃疡性结肠炎罕见并存,掩盖了症状的真正病因。
Cureus. 2024 Aug 1;16(8):e65977. doi: 10.7759/cureus.65977. eCollection 2024 Aug.
7
Cardiac Evaluation before and after Oral Propranolol Treatment for Infantile Hemangiomas.口服普萘洛尔治疗婴儿血管瘤前后的心脏评估
J Clin Med. 2024 Jun 5;13(11):3332. doi: 10.3390/jcm13113332.
8
Efficacy of foam sclerotherapy with polidocanol for the management of oral venous malformations.聚多卡醇泡沫硬化疗法治疗口腔静脉畸形的疗效
Med Int (Lond). 2024 Mar 26;4(3):24. doi: 10.3892/mi.2024.148. eCollection 2024 May-Jun.
9
Acquired cryptorchidism: an unexpected consequence of inguinoscrotal lymphatic malformation treated with Eppikajutsuto.获得性隐睾:Eppikajutsuto 治疗腹股沟-阴囊淋巴管畸形的意外后果。
BMJ Case Rep. 2021 Oct 4;14(10):e243346. doi: 10.1136/bcr-2021-243346.
10
Update on infantile hemangioma.婴儿血管瘤的最新进展。
Clin Exp Pediatr. 2021 Nov;64(11):559-572. doi: 10.3345/cep.2020.02061. Epub 2021 May 26.
Pediatr Endocrinol Rev. 2015 Mar;12(3):308-10.
4
A randomized, controlled trial of oral propranolol in infantile hemangioma.口服普萘洛尔治疗婴儿血管瘤的随机对照试验。
N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.
5
Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?: A cohort study.心血管评估是否有必要在婴幼儿血管瘤的β受体阻滞剂治疗之前和期间进行?一项队列研究。
J Am Acad Dermatol. 2015 Mar;72(3):465-72. doi: 10.1016/j.jaad.2014.12.019. Epub 2015 Jan 13.
6
Combination therapy of infantile hemangioma with pulsed dye laser with topical propranolol: a randomized clinical trial.脉冲染料激光联合外用普萘洛尔治疗婴幼儿血管瘤:一项随机临床试验。
Arch Iran Med. 2014 Oct;17(10):657-60.
7
Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.儿童静脉畸形十四酸钠硬化治疗后的神经病变。
Radiology. 2015 Mar;274(3):897-905. doi: 10.1148/radiol.14132271. Epub 2014 Sep 29.
8
Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences.阿司匹林治疗静脉畸形:一项关于益处、副作用及患者体验的回顾性队列研究。
Pediatr Dermatol. 2014 Sep-Oct;31(5):556-60. doi: 10.1111/pde.12373. Epub 2014 Jul 21.
9
Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.博来霉素硬化疗法治疗微囊型淋巴管畸形的安全性和有效性。
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1476-81. doi: 10.1007/s00270-014-0932-z. Epub 2014 Jun 19.
10
A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.平阳霉素硬化疗法治疗静脉畸形的临床研究:对281例连续患者的评估
J Clin Pharm Ther. 2014 Oct;39(5):521-6. doi: 10.1111/jcpt.12183. Epub 2014 Jun 13.